Top Stock Gainers: NextCure, Twin Vee, and SK Hynix Lead Market Surge

Font: Financial Modeling Prep  • Jul 14, 2026

• NextCure, Inc. (NASDAQ: NXTC) stock soared over 201% following an all-stock merger with Avere Therapeutics, advancing a key psoriasis drug candidate.
• Twin Vee Powercats Co. (NASDAQ: VEEE) experienced a 54.91% stock increase, driven by strong investor confidence in its new electric and gas-powered boat models.
• SK hynix Inc. (OTCMKTS: SKHY) saw its ADRs rise 27.29%, highlighting its critical role in the semiconductor industry and influencing leveraged ETFs.

Today's market highlights several top gainers with major price increases. Key movers include the biopharmaceutical firm NextCure, Inc. (NASDAQ: NXTC) and boat manufacturer Twin Vee Powercats Co. (NASDAQ: VEEE). The semiconductor giant SK hynix Inc. (OTCMKTS: SKHY) also shows strong performance, influencing related exchange-traded funds (ETFs).

NextCure stock surges over 201%, an increase of $4.40 to $6.58 per share. This follows news of an all-stock merger with Avere Therapeutics. The deal, which takes Avere public, provides $320 million in financing to advance its main drug candidate, an oral psoriasis therapy known as AVR-001.

Twin Vee sees its stock jump 54.91%, or $13.65, to close at $38.51. The company, which builds and sells powered catamaran boats, is developing new electric and gas-powered models. The significant price increase on a trading volume of over 22.9 million shares points to strong investor confidence in its products.

The memory chip maker SK Hynix experiences a robust 27.29% rise in its ADRs, reaching $193.92. As Jim Cramer notes, the tech industry is a 'hostage' to SK Hynix, underscoring its critical role for companies like Nvidia. This importance is a key driver of the stock's recent growth.

Reflecting this trend, leveraged ETFs tracking the company also climb. The T-REX 2X Long SK Hynix Daily Target ETF (NASDAQ: HYNX) is up 28.72%, while the GraniteShares 2x Long SK Hynix Daily ETF (NASDAQ: SKUU) gains 28.14%. These funds use derivatives to seek 200% of the daily return of SK Hynix stock and are for short-term trading.

In summary, today's market movements are driven by distinct factors. NextCure's growth is fueled by a strategic merger, while SK Hynix's rise is tied to its essential position in the tech sector. Twin Vee's performance reflects strong investor belief in its specialized market, showcasing how different catalysts can impact stock prices.